EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Immunomodulatory Effects of Molecular Hydrogen Therapy in Systemic Lupus Erythematosus With Pericarditis and Pleuritis: A Case Report

Ting-Hao Tu, Jeng-Wei Lu, Yi-Jung Ho, Shan-Wen Lui, Ting-Yu Hsieh, Kuang-Yih Wang, Feng-Cheng Liu

In Vivo · 2025

DOI: 10.21873/invivo.14103 ↗

Kurz gefasst

Fallbericht in der Zeitschrift In Vivo, 2025. Verfasst von Ting-Hao Tu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Pleurisy, Pericarditis, Hydrogen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Pericarditis is a common cardiovascular complication associated with systemic lupus erythematosus (SLE). Oxidative stress plays a significant role in disease pathology. Molecular hydrogen has emerged as a promising therapeutic option with its antioxidant, anti-inflammatory, and antiapoptotic properties. While prior studies have demonstrated its cardioprotective effects, research on its immunomodulatory potential in autoimmune diseases remains limited; therefore, this article presents a case study with SLE experiencing pericarditis and pleuritis, receiving hydrogen therapy in October 2024 as part of an effort to evaluate its potential in modulating immune responses and alleviating disease symptoms. CASE REPORT: This is the case of a 49-year-old Taiwanese female diagnosed with SLE, alongside pericarditis, pleuritis, and multi-organ impairments. Despite initial treatment and intermittent follow-ups, the patient experienced recurrent disease exacerbations, which was managed with immunomodulatory therapies. In October 2024, molecular hydrogen supplementation was introduced as an adjuvant therapy. Immunophenotypic analysis revealed dynamic changes in the percentages of immune cells, with decreasing trend of Tr1 cells and increasing trend of naïve Treg cells, B cell subsets expressing Fas, and transitional B cells following molecular hydrogen therapy. CONCLUSION: Molecular hydrogen therapy had potential to modulate immune markers in this case study. Further investigation into its clinical efficacy and safety is necessary for the development of treatment guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicPleurisyPericarditisHydrogenImmunomodulationHumansFemaleMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

Case reporthydrogen therapypericarditispleuritissystemic lupus erythematosus

Substanzen

Hydrogen

Autor:innen und Institutionen

  • Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan, R.O.C.
  • Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
  • The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, R.O.C.

Zitieren

APA

Tu, T. H., Lu, J. W., Ho, Y. J., Lui, S. W., Hsieh, T. Y., Wang, K. Y., & Liu, F. C. (2025). Immunomodulatory Effects of Molecular Hydrogen Therapy in Systemic Lupus Erythematosus With Pericarditis and Pleuritis: A Case Report. In Vivo. https://doi.org/10.21873/invivo.14103

Vancouver

Tu TH, Lu JW, Ho YJ, Lui SW, Hsieh TY, Wang KY, et al. Immunomodulatory Effects of Molecular Hydrogen Therapy in Systemic Lupus Erythematosus With Pericarditis and Pleuritis: A Case Report. In Vivo. 2025. doi:10.21873/invivo.14103

BibTeX
@article{Tu2025,
  author = {Tu, Ting-Hao and Lu, Jeng-Wei and Ho, Yi-Jung and Lui, Shan-Wen and Hsieh, Ting-Yu and Wang, Kuang-Yih and Liu, Feng-Cheng},
  title = {Immunomodulatory Effects of Molecular Hydrogen Therapy in Systemic Lupus Erythematosus With Pericarditis and Pleuritis: A Case Report},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.14103}
}
Kostenlos starten →